Coronavirus

oldngray

nowhere special
wash-your-hands-1.jpg
 

Jones

fILE A GRIEVE!
Staff member
Very promising if the research can be replicated:

But how effective is the drug? This week, researcher Didier Raoult from Aix-Marseille University in France, one of the main proponents for using hydroxychloroquine to treat infection with the novel coronavirus—known as SARS-CoV-2—released encouraging results of a preliminary trial involving a total of 36 COVID-19 patients.
According to a draft paper—which has not yet been accepted for publication in a peer-reviewed scientific journal—six of these patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.

Between early and mid-March, Raoult and his team treated 20 of these patients with 600 milligrams of hydroxychloroquine daily in a hospital setting. Depending on their symptoms, an antibiotic known as azithromycin was also added to the treatments. This antibiotic is known to be effective against complications from bacterial lung disease. The 16 remaining patients were not given the drug as a control.

In the study, the scientists observed a "significant" reduction in viral load in the patients treated with hydroxychloroquine, and that the effect was reinforced by azithromycin, Medscape reported.

In fact, after six days, 70 percent of the treated patients were considered cured, meaning that the virus was no longer detected in samples taken from them, compared to 12.5 percent of the control group patients. Furthermore, all six patients who were treated with both hydroxychloroquine and the antibiotic azithromycin tested negative for the virus after six days.
While encouraging, it is important to note that this is an unpublished preliminary study, so the results should be viewed with caution. The sample size is small, and the study was non-randomized, meaning people were allocated to different interventions using non-random methods. The study was also "unblinded," meaning that all parties—i.e. the medical staff, patients and researchers—were aware of the treatments the participants received.


Donald Trump Says Malaria Drug for Coronavirus Has Been Approved by FDA
 

oldngray

nowhere special
Very promising if the research can be replicated:

But how effective is the drug? This week, researcher Didier Raoult from Aix-Marseille University in France, one of the main proponents for using hydroxychloroquine to treat infection with the novel coronavirus—known as SARS-CoV-2—released encouraging results of a preliminary trial involving a total of 36 COVID-19 patients.
According to a draft paper—which has not yet been accepted for publication in a peer-reviewed scientific journal—six of these patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.

Between early and mid-March, Raoult and his team treated 20 of these patients with 600 milligrams of hydroxychloroquine daily in a hospital setting. Depending on their symptoms, an antibiotic known as azithromycin was also added to the treatments. This antibiotic is known to be effective against complications from bacterial lung disease. The 16 remaining patients were not given the drug as a control.

In the study, the scientists observed a "significant" reduction in viral load in the patients treated with hydroxychloroquine, and that the effect was reinforced by azithromycin, Medscape reported.

In fact, after six days, 70 percent of the treated patients were considered cured, meaning that the virus was no longer detected in samples taken from them, compared to 12.5 percent of the control group patients. Furthermore, all six patients who were treated with both hydroxychloroquine and the antibiotic azithromycin tested negative for the virus after six days.
While encouraging, it is important to note that this is an unpublished preliminary study, so the results should be viewed with caution. The sample size is small, and the study was non-randomized, meaning people were allocated to different interventions using non-random methods. The study was also "unblinded," meaning that all parties—i.e. the medical staff, patients and researchers—were aware of the treatments the participants received.


Donald Trump Says Malaria Drug for Coronavirus Has Been Approved by FDA

That drug sounds promising but I take the French researcher's claims with a grain of salt. Doesn't seem to be any down side to trying his treatment so go ahead with them.
 

tonyexpress

Whac-A-Troll Patrol
Staff member
The World May Be Ending: Ilhan Omar Praises President Trump’s ‘Incredible and Right Response’ In Virus Fight

Omar said on Wednesday night that Trump’s response to the pandemic was “incredible and the right response in this critical time.”

Omar, normally a staunch critic of the White House who herself has repeatedly drawn the president’s ire, went on to quote Rep. Ayanna Pressley, D-Mass., as saying “unprecedented times require unprecedented leadership” — and, Omar added, “we are seeing that in our country right now.”
 

brownmonster

Man of Great Wisdom
"It could have a very positive effect, or a positive effect, maybe not very, but maybe positive," Trump said. "It’s very, very exciting". And Joe is a mumbling fool.
 

El Correcto

god is dead
Very promising if the research can be replicated:

But how effective is the drug? This week, researcher Didier Raoult from Aix-Marseille University in France, one of the main proponents for using hydroxychloroquine to treat infection with the novel coronavirus—known as SARS-CoV-2—released encouraging results of a preliminary trial involving a total of 36 COVID-19 patients.
According to a draft paper—which has not yet been accepted for publication in a peer-reviewed scientific journal—six of these patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.

Between early and mid-March, Raoult and his team treated 20 of these patients with 600 milligrams of hydroxychloroquine daily in a hospital setting. Depending on their symptoms, an antibiotic known as azithromycin was also added to the treatments. This antibiotic is known to be effective against complications from bacterial lung disease. The 16 remaining patients were not given the drug as a control.

In the study, the scientists observed a "significant" reduction in viral load in the patients treated with hydroxychloroquine, and that the effect was reinforced by azithromycin, Medscape reported.

In fact, after six days, 70 percent of the treated patients were considered cured, meaning that the virus was no longer detected in samples taken from them, compared to 12.5 percent of the control group patients. Furthermore, all six patients who were treated with both hydroxychloroquine and the antibiotic azithromycin tested negative for the virus after six days.
While encouraging, it is important to note that this is an unpublished preliminary study, so the results should be viewed with caution. The sample size is small, and the study was non-randomized, meaning people were allocated to different interventions using non-random methods. The study was also "unblinded," meaning that all parties—i.e. the medical staff, patients and researchers—were aware of the treatments the participants received.


Donald Trump Says Malaria Drug for Coronavirus Has Been Approved by FDA
Okay good, everyone get back to work. I’m sick of California shutting down the economy to beg for money from the union.
 

tonyexpress

Whac-A-Troll Patrol
Staff member
Without California and NYC the rest of the country would be third world.

Not only is California taxing too much, importing 3rd world poverty by being a sanctuary State, promoting death on the streets with not fixing the homeless problem, but they're also running jobs out of California by promoting assembly bill 5 introduced by leftist assembly nut, Lorena Gonzalez with the full support of Governor Hair jell, Gavin Newsome.

Assemblywoman Lorena Gonzalez Blatantly Lies in Saying that AB 5 has not Caused Job Loss

Mary Konstantinidou is, or was, a Greek translator in San Diego and an independent contractor. She voted for Assemblywoman Gonzalez, but now AB 5 has made her job impossible. In response to Konstantinidou’s criticism, Gonzalez responded, “I’m sorry and I feel that she does feel that way. But I don’t think it is true.” Whether or not Gonzalez ‘feels’ that the critique is true is irrelevant, when faced with evidence that her bill is hurting her constituents she turns her back on them.

AB 5 is already hurting California’s economy, and Gonzalez is simply ignoring the facts because they do not suit her narrative. Only the largest corporations like Uber might be able to survive and stay profitable while transitioning all of their independent contractors to employees. Smaller companies that contract out work like yard work or delivery services will be forced to cut ties with their contractors because they cannot afford to pay benefits to their new employees.

The California Trucking Association made a statement that AB 5 will cause the loss of roughly 70,000 trucking jobs in California. Some California truckers are already packing up their families and moving out of state to find new work. Freelance journalists are actually suing the state of California over AB 5 because as employees, their work would belong to their employers and they would no longer have control over the pieces that they write.

Common sense is lacking in California politics.
 
Top